TP53 and breast carcinoma: The top 4% of breast cancers had an overrepresentation of TP53 mutations (p < 0.0001) and an underrepresentation PIK3CA mutations (p = 0.046), also corresponding to the molecular features that we observed in micropapillary CRC.